Breakthroughs are in the biotech genes
The ‘genomics capital’ of the world will showcase some of the biotechnology industry’s major breakthroughs next week.
San Diego is hosting the BIO International Conventional – the global event for biotechnology – under the theme: ‘Breakthroughs’. Around 16,000 biotech leaders will be there for what is regarded as the most important annual meeting place for the entire industry.
San Diego Mayor Kevin Faulconer said it “is the perfect host city for BIO 2017” as it is “the center of the genomics universe”.
And after what Jim Greenwood, the President & CEO of event organiser’s the Biotechnology Innovation Organization (BIO), calls a “year of eureka moments” for the industry, he said “the perfect theme for BIO 2017 is “Breakthrough”.
On medical breakthroughs, he said: “New CRISPR gene editing technology has cured Hepatitis B in mice and shown early promise in the treatment of human diseases like leukemia and HIV. Human clinical trials on CRISPR medicines begin in the United States this year. What better place to discuss the potential of this ground-breaking technology than in the “genomics capital” where San Diego’s J. Craig Venter (along with Francis Collins) first mapped the human genome back in 2000.”
And there will some special guests. “NASA astronaut Kate Rubins will tell us about becoming the first person to sequence DNA in outer space during her 115 day expedition through the stars,” added Jim.
While former British Prime Minister David Cameron will be in town to share his thoughts on the likely impact his Brexit vote will have on the biotechnology industry.
The BIO International Conventional will take place at the San Diego Convention Center between 19 and 22 June.
$10M for birthplace of biotechnology
The “birthplace of biotechnology” is to receive $10 million for a pioneering precision medicine programme.
It was announced this week that the California Initiative to Advance Precision Medicine (CIAPM) has been awarded the money from the local government’s budget, a decision welcomed by the California Life Sciences Association (CLSA).
Sara Radcliffe, President & CEO, CLSA, said: “California Life Sciences Association (CLSA) applauds Governor Jerry Brown, California State Senate and California Assembly leaders for their strong support of life sciences innovation, as demonstrated again in this year’s 2017-2018 budget deal which allocates a $10 million investment in precision medicine research. California is the birthplace of biotechnology and today the state’s life sciences sector employs over 287,200 people working to develop innovative new medicines, technologies and therapies needed to treat and cure patients.”
The Californian city of San Diego is hosting the BIO International Conventional – the global event for biotechnology – next week. It will celebrate the industry’s many breakthroughs and on going impact on society. It will take place at the San Diego Convention Center between 19 and 22 June.
Source & Credit @ Innovators Magazine. Link to the original article is HERE.